Family Office · Mt Waverley, VIC, Australia
D4 Bioventures is a venture capital firm focused on investing in early-stage biotechnology and life sciences companies. The firm specializes in supporting startups that are developing innovative therapeutics and technologies in areas such as drug discovery, diagnostics, and healthcare solutions. D4 Bioventures is known for its hands-on approach, providing both capital and strategic guidance to portfolio companies. The firm is headquartered in the United States and is recognized for its involvement in advancing cutting-edge biomedical research and fostering the growth of emerging biotech enterprises.
Business models
deeptech_ip, biotech_therapeutics
Customer segments
Enterprise, Researchers, Medical Research Institutes, Startups
Geography
Australia, APAC
We never publish partner emails directly — score your deck to unlock contacts for the firms ranked as best-fit.
D4 Bioventures deploys privately-held capital. Cycles are short, decisions concentrated, and structures flexible (equity, convertible, revenue-share). Less brand premium, more underwriting on substance. VCboom tracks D4 Bioventures alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.
Seed VC
Aktiebolag Grenspecialisten
software, diagnostics, life science
Family Office
Transocean Group
financial services, healthcare, medtech
Family Office
Bioworld Ventures
biopharma, medtech, orthopedics
Seed VC
Impilo
pharmaceutical, medtech, specialist pharma services
Seed VC
Cocoon Capital
deeptech_ip, enterprise_tech, robotics
Family Office
LionRock Capital
technology, consumer, healthcare
Drop your pitch. AI scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. D4 Bioventures is one of them — and we'll tell you exactly where they sit in your top 100.